Search the web
Welcome, Guest
[Sign Out, My Account]

Tuesday, October 25 2016 11:21pm ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic
More On This Industry
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
Industry Market Summary
Drugs - Generic
Composite Value: 940.5
Today's Change: -0.32%
S&P 500: -0.39%
chart for
[Drugs - Generic (^YHOh785)]
Drugs - Generic News
JUNIPER (JNP) ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigation of Juniper Pharmaceuticals, Inc.; Encourages Long-Term Investors to Contact the Firm
Tue 9:59 am ET (PR Newswire)
SAN DIEGO, Oct. 25, 2016 /PRNewswire/ -- Johnson & Weaver, LLP has commenced an investigation concerning whether Juniper Pharmaceuticals, Inc. (NASDAQ: JNP) violated federal or state securities laws. Juniper ...
SCYNEXIS Completes Two Additional Clinical Studies Further Supporting the Favorable Safety Profile of SCY-078 - (GlobeNewswire)
KYBELLA® (deoxycholic acid) injection 10 mg/mL Puts "Profiles in Focus" With Expert Panel And New Direct-To-Consumer Campaign - (PR Newswire)
More News on Drugs - Generic: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
ALLERGAN [AGNN.MX] -1.71% $1693.9 B
LUPIN LTD. [LUPIN.BO] -0.32% $710.7 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
10/25/16 000513.SZ Livzon Pharmaceutical Group Inc Q3 2016 Earnings Release
10/25/16 000623.SZ Jilin Aodong Pharmaceutical Group Co Ltd Q3 2016 Earnings Release
10/25/16 600535.SS Tasly Pharmaceutical Group Co Ltd Q3 2016 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
10/20/16 CTLT Catalent, Inc. coverage initiated by KeyBanc Capital Mkts
10/20/16 SCYX SCYNEXIS, Inc. coverage initiated by H.C. Wainwright
10/18/16 NBIX Neurocrine Biosciences, Inc. coverage initiated by Needham
More Recent Events...
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:4B
Price / Earnings:NM
Price / Book:-4.3
Net Profit Margin (mrq):-4.8%
Price To Free Cash Flow (mrq):-7.3
Return on Equity:0.0%
Total Debt / Equity:45.5
Dividend Yield:0.5%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
Unusually Active Boards
Board Variance

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?